A science based approach to topical drug classification system (TCS)
- PMID: 26070249
- DOI: 10.1016/j.ijpharm.2015.06.011
A science based approach to topical drug classification system (TCS)
Abstract
The Biopharmaceutics Classification System (BCS) for oral immediate release solid drug products has been very successful; its implementation in drug industry and regulatory approval has shown significant progress. This has been the case primarily because BCS was developed using sound scientific judgment. Following the success of BCS, we have considered the topical drug products for similar classification system based on sound scientific principles. In USA, most of the generic topical drug products have qualitatively (Q1) and quantitatively (Q2) same excipients as the reference listed drug (RLD). The applications of in vitro release (IVR) and in vitro characterization are considered for a range of dosage forms (suspensions, creams, ointments and gels) of differing strengths. We advance a Topical Drug Classification System (TCS) based on a consideration of Q1, Q2 as well as the arrangement of matter and microstructure of topical formulations (Q3). Four distinct classes are presented for the various scenarios that may arise and depending on whether biowaiver can be granted or not.
Keywords: Bioequivalence; Biowaiver; In vitro release; SUPAC-SS; Topical dosage forms; Topical drug classification system.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Commonality between BCS and TCS.Int J Pharm. 2016 Jul 25;509(1-2):35-40. doi: 10.1016/j.ijpharm.2016.05.032. Epub 2016 May 18. Int J Pharm. 2016. PMID: 27208656 Review.
-
Development of performance matrix for generic product equivalence of acyclovir topical creams.Int J Pharm. 2014 Nov 20;475(1-2):110-22. doi: 10.1016/j.ijpharm.2014.07.034. Epub 2014 Jul 30. Int J Pharm. 2014. PMID: 25089511
-
Effect of the Similarity of Formulations and Excipients of Approved Generic Drug Products on In Vivo Bioequivalence for Putative Biopharmaceutics Classification System Class III Drugs.Pharmaceutics. 2023 Sep 21;15(9):2366. doi: 10.3390/pharmaceutics15092366. Pharmaceutics. 2023. PMID: 37765334 Free PMC article.
-
Biowaiver monographs for immediate release solid oral dosage forms: piroxicam.J Pharm Sci. 2014 Feb;103(2):367-77. doi: 10.1002/jps.23799. Epub 2013 Dec 2. J Pharm Sci. 2014. PMID: 24301077
-
Biopharmaceutics classification system-based biowaivers for generic oncology drug products: case studies.AAPS PharmSciTech. 2015 Feb;16(1):5-9. doi: 10.1208/s12249-014-0195-7. Epub 2014 Sep 23. AAPS PharmSciTech. 2015. PMID: 25245330 Free PMC article. Review.
Cited by
-
Update on the advances and challenges in bioequivalence testing methods for complex topical generic products.Front Pharmacol. 2024 Feb 8;15:1330712. doi: 10.3389/fphar.2024.1330712. eCollection 2024. Front Pharmacol. 2024. PMID: 38389924 Free PMC article. Review.
-
The Science of Selecting Excipients for Dermal Self-Emulsifying Drug Delivery Systems.Pharmaceutics. 2023 Apr 20;15(4):1293. doi: 10.3390/pharmaceutics15041293. Pharmaceutics. 2023. PMID: 37111778 Free PMC article. Review.
-
Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union.Pharmaceutics. 2023 Feb 10;15(2):601. doi: 10.3390/pharmaceutics15020601. Pharmaceutics. 2023. PMID: 36839924 Free PMC article. Review.
-
The Assessment of Skin Homeostasis Changes after Using Different Types of Excipients in Healthy Individuals.Int J Environ Res Public Health. 2022 Dec 12;19(24):16678. doi: 10.3390/ijerph192416678. Int J Environ Res Public Health. 2022. PMID: 36554558 Free PMC article.
-
Structural Characterization and Optimization of a Miconazole Oral Gel.Polymers (Basel). 2022 Nov 18;14(22):5011. doi: 10.3390/polym14225011. Polymers (Basel). 2022. PMID: 36433136 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
